Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:disease
|
| gptkbp:affects |
muscle strength
|
| gptkbp:associated_with |
thymoma
|
| gptkbp:can_lead_to |
difficulty swallowing
double vision drooping eyelids |
| gptkbp:caused_by |
autoimmune response
|
| gptkbp:complication |
respiratory failure
myasthenic crisis thymic tumors |
| gptkbp:diagnosis |
gptkb:lambert-eaton_syndrome
gptkb:Guillain-Barré_syndrome gptkb:muscular_dystrophy gptkb:multiple_sclerosis stroke variable chronic condition electromyography potential for remission |
| gptkbp:first_described_by |
1895
|
| https://www.w3.org/2000/01/rdf-schema#label |
myasthenia gravis
|
| gptkbp:is |
gptkb:disease
gptkb:Oncology hereditary infectious degenerative disease |
| gptkbp:is_common_in |
gptkb:women
young adults adults elderly men young women middle-aged men |
| gptkbp:is_managed_by |
gptkb:surgery
physical therapy lifestyle changes intravenous immunoglobulin plasma exchange |
| gptkbp:is_studied_in |
gptkb:medical_research
clinical trials neurology |
| gptkbp:premiered_on |
any age
|
| gptkbp:prevalence |
14 to 20 per 100,000 people
|
| gptkbp:related_to |
acetylcholine receptors
neuromuscular junction |
| gptkbp:research_focus |
new medications
biological therapies thymectomy |
| gptkbp:symptoms |
fatigue
muscle weakness |
| gptkbp:treatment |
gptkb:immunotherapy
gptkb:Android monoclonal antibodies immunosuppressants anticholinesterase medications |
| gptkbp:bfsParent |
gptkb:ALS
gptkb:scopolamine |
| gptkbp:bfsLayer |
4
|